Immune cells take on childhood cancer in new trial
NCT ID NCT02573896
First seen Mar 24, 2026 · Last updated May 06, 2026 · Updated 4 times
Summary
This early-stage trial tests a new combination treatment for children with neuroblastoma that has come back or not responded to standard therapy. It uses the child's own natural killer (NK) cells, grown in a lab, along with an antibody drug (dinutuximab) and sometimes a drug called lenalidomide. The main goal is to find the safest dose of NK cells and see if adding lenalidomide is possible. About 13 children up to age 30 are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, 30322, United States
-
C.S Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
-
Children's Hospital Los Angeles
Los Angeles, California, 90027-0700, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104-4318, United States
-
Childrens Hospital Boston, Dana-Farber Cancer Institute.
Boston, Massachusetts, 02115, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
-
Cook Children's Healthcare System
Fort Worth, Texas, 76104, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
-
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94115, United States
-
University of Chicago Comer Children's Hospital
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.